Ontology highlight
ABSTRACT:
PROVIDER: EGAD00001003315 | EGA |
REPOSITORIES: EGA
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20170512 26
Purpose Histologic transformation of EGFR mutant lung adenocarcinoma (LADC) into small-cell lung cancer (SCLC) has been described as one of the major resistant mechanisms for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). However, the molecular pathogenesis is still unclear. Methods We investigated 21 patients with advanced EGFR-mutant LADCs that were transformed into EGFR TKI-resistant SCLCs. Among them, whole genome sequencing was applied for nine tumors acquired at ...[more]